Melatonin Ameliorates Abnormal Sleep-Wake Behavior via Facilitating Lipid Metabolism in a Zebrafish Model of Parkinson’s Disease
- 16 September 2024
- journal article
- research article
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 40 (12) , 1901-1914
Abstract
Sleep-wake disorder is one of the most common nonmotor symptoms of Parkinson's disease (PD). Melatonin has the potential to improve sleep-wake disorder, but its mechanism of action is still unclear. Our data showed that melatonin only improved the motor and sleep-wake behavior of a zebrafish PD model when melatonin receptor 1 was present. Thus, we explored the underlying mechanisms by applying a rotenone model. After the PD zebrafish model was induced by 10 nmol/L rotenone, the motor and sleep-wake behavior were assessed. In situ hybridization and real-time quantitative PCR were used to detect the expression of melatonin receptors and lipid-metabolism-related genes. In the PD model, we found abnormal lipid metabolism, which was reversed by melatonin. This may be one of the main pathways for improving PD sleep-wake disorder.Keywords
This publication has 57 references indexed in Scilit:
- Sleep-promoting effects of the GABA/5-HTP mixture in vertebrate modelsBehavioural Brain Research, 2016
- Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamicsMovement Disorders, 2014
- Are Sleep Disturbances Preclinical Markers of Parkinson’s Disease?Neurochemical Research, 2014
- Zebrafish as an emerging model for studying complex brain disordersTrends in Pharmacological Sciences, 2014
- Circadian rhythms, sleep, and metabolismJournal of Clinical Investigation, 2011
- Sleep and its regulation in zebrafishReviews in the Neurosciences, 2011
- Insufficient Sleep Undermines Dietary Efforts to Reduce AdiposityAnnals of Internal Medicine, 2010
- High-resolution in situ hybridization to whole-mount zebrafish embryosNature Protocols, 2007
- Expression and functional characterization of the mt1 melatonin receptor from rat brain in Xenopus oocytes: evidence for coupling to the phosphoinositol pathwayJournal of Pineal Research, 2001
- Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implicationsJournal of Pineal Research, 1997